Dark | Light
# Genelux Corporation (GNLX)

Genelux Corporation (GNLX) sees a surge in social mentions and creator activity, with significant increases in social dominance. The company is advancing clinical trials, but market sentiment and valuation concerns are impacting its stock price.

### About Genelux Corporation
Genelux Corporation is a biotechnology company focused on developing novel cancer therapies.  
Genelux Corporation uses the ticker $GNLX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Genelux Corporation (GNLX) mentions hit [--] which is 332% higher than it's daily average.
- Genelux Corporation (GNLX) creators hit [--] which is 207% higher than it's daily average.
- Genelux Corporation (GNLX) social dominance hit [------] which is 283% higher than it's daily average.
- Genelux Corporation (GNLX) market cap is up 11.11% from the previous week.
- Genelux Corporation (GNLX) social dominance is up 1920% from the previous [--] months.
- Genelux Corporation (GNLX) Galaxy Score™ is up 113.04% from the previous week.

### Price: $2.60
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:genelux-corporation/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/close.tsv)  
The stock price has declined by -31.35% over the last [--] days, attributed to a market sentiment shift and valuation concerns, overriding positive news about clinical trial progress. The current price of $2.40 is near its 1-year low.  

24-Hour: 4.82%
7-Day: 9.66%
30-Day: -4.74%

1-Year High: $8.20 on 2025-11-03  
1-Year Low: $2.40 on 2026-02-05  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:genelux-corporation/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/alt_rank.tsv)  
Genelux Corporation (GNLX) is currently AltRank #2,481 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +221  
1-Year High: [-----] on 2026-01-27  
1-Year Low: [---] on 2026-01-25  
  
  
### Galaxy Score: [--]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:genelux-corporation/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/galaxy_score.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] +26  
1-Year High: [--] on 2026-01-25  
1-Year Low: [--] on 2026-01-28  
  
  
### Engagements: [---] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:genelux-corporation/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/interactions.tsv)  
Current Value: [---]  
Daily Average: [-----]  
[--] Week: [-----] -7.50%  
[--] Month: [-----] -95%  
[--] Months: [-------] +28%  
[--] Year: [-------] -13%  
1-Year High: [------] on 2025-12-15  
1-Year Low: [--] on 2025-08-09  

Engagements by network (24h):
X: [---]
Reddit: [--]
News: [---]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:genelux-corporation/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] -4.80%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-08-09  

Mentions by network (24h):
X: [--]
Reddit: [--]
News: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:genelux-corporation/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Genelux Corporation (GNLX) in the last [--] hours which is up 360% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] -13%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-08-09  
  
  
### Sentiment: 67%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:genelux-corporation/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/sentiment.tsv)  
Current Value: 67%  
Daily Average: 85%  
[--] Week: 57% -43%  
[--] Month: 60% +10%  
[--] Months: 60% -40%  
[--] Year: 60% -7%  
1-Year High: 100% on 2025-02-16  
1-Year Low: 10% on 2025-06-14  

Most Supportive Themes:
- Clinical Trial Progress: (40%) Genelux Corporation is advancing its clinical trials, with a recent announcement about dosing the first patient in a Phase [--] trial for Non-Small Cell Lung Cancer.
- Financial Performance: (30%) The company has reported its financial results, indicating its ongoing operational and financial standing.
- Strategic Partnerships and Conferences: (30%) Genelux Corporation is actively participating in industry conferences and engaging in strategic discussions, as evidenced by their participation in the Guggenheim Healthcare Innovation Conference.
  
Most Critical Themes:
- Market Sentiment Shift: (70%) Despite positive news, the stock price has seen a significant decline over the past [--] days, suggesting a potential disconnect between company developments and market valuation.
- Valuation Concerns: (30%) The current price is considerably lower than its 1-year high, and the market cap has also seen a decrease, raising questions about the stock's current valuation.
  
  
  
### Social Dominance: 0.00547%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:genelux-corporation/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/social_dominance.tsv)  
Current Value: 0.00547%  
Daily Average: 0.00248%  
[--] Week: 0.00542% +0.00502%  
[--] Month: 0.01% +0.0093%  
[--] Months: 0.01% +0.0096%  
[--] Year: 0.01% +0.006%  
1-Year High: 0.031% on 2025-06-29  
1-Year Low: 0.0001% on 2025-08-09  
  
  
### Market Dominance: 0.00013217853443729305%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:genelux-corporation/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/market_dominance.tsv)  
Current Value: 0.00013217853443729305%  
Daily Average: 0%  
1-Year High: 0.00513% on 2026-02-13  
1-Year Low: 0.00013% on 2026-02-15  
  
  
### Market Cap: $116,715,123
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:genelux-corporation/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/genelux-corporation/time-series/market_cap.tsv)  
Current Value: $116,715,123  
Daily Average: $118,872,130  
[--] Week: $116,267,939 +11%  
[--] Month: $116,715,123 -4.70%  
1-Year High: $132,366,576 on 2026-01-27  
1-Year Low: $105,088,329 on 2026-02-05

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Genelux Corporation (GNLX)

Genelux Corporation (GNLX) sees a surge in social mentions and creator activity, with significant increases in social dominance. The company is advancing clinical trials, but market sentiment and valuation concerns are impacting its stock price.

About Genelux Corporation

Genelux Corporation is a biotechnology company focused on developing novel cancer therapies.
Genelux Corporation uses the ticker $GNLX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Genelux Corporation (GNLX) mentions hit [--] which is 332% higher than it's daily average.
  • Genelux Corporation (GNLX) creators hit [--] which is 207% higher than it's daily average.
  • Genelux Corporation (GNLX) social dominance hit [------] which is 283% higher than it's daily average.
  • Genelux Corporation (GNLX) market cap is up 11.11% from the previous week.
  • Genelux Corporation (GNLX) social dominance is up 1920% from the previous [--] months.
  • Genelux Corporation (GNLX) Galaxy Score™ is up 113.04% from the previous week.

Price: $2.60

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price has declined by -31.35% over the last [--] days, attributed to a market sentiment shift and valuation concerns, overriding positive news about clinical trial progress. The current price of $2.40 is near its 1-year low.

24-Hour: 4.82% 7-Day: 9.66% 30-Day: -4.74%

1-Year High: $8.20 on 2025-11-03
1-Year Low: $2.40 on 2026-02-05

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Genelux Corporation (GNLX) is currently AltRank #2,481 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] +221
1-Year High: [-----] on 2026-01-27
1-Year Low: [---] on 2026-01-25

Galaxy Score: [--]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] +26
1-Year High: [--] on 2026-01-25
1-Year Low: [--] on 2026-01-28

Engagements: [---] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [-----]
[--] Week: [-----] -7.50%
[--] Month: [-----] -95%
[--] Months: [-------] +28%
[--] Year: [-------] -13%
1-Year High: [------] on 2025-12-15
1-Year Low: [--] on 2025-08-09

Engagements by network (24h): X: [---] Reddit: [--] News: [---]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] -4.80%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-08-09

Mentions by network (24h): X: [--] Reddit: [--] News: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Genelux Corporation (GNLX) in the last [--] hours which is up 360% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] -13%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-08-09

Sentiment: 67%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 67%
Daily Average: 85%
[--] Week: 57% -43%
[--] Month: 60% +10%
[--] Months: 60% -40%
[--] Year: 60% -7%
1-Year High: 100% on 2025-02-16
1-Year Low: 10% on 2025-06-14

Most Supportive Themes:

  • Clinical Trial Progress: (40%) Genelux Corporation is advancing its clinical trials, with a recent announcement about dosing the first patient in a Phase [--] trial for Non-Small Cell Lung Cancer.
  • Financial Performance: (30%) The company has reported its financial results, indicating its ongoing operational and financial standing.
  • Strategic Partnerships and Conferences: (30%) Genelux Corporation is actively participating in industry conferences and engaging in strategic discussions, as evidenced by their participation in the Guggenheim Healthcare Innovation Conference.

Most Critical Themes:

  • Market Sentiment Shift: (70%) Despite positive news, the stock price has seen a significant decline over the past [--] days, suggesting a potential disconnect between company developments and market valuation.
  • Valuation Concerns: (30%) The current price is considerably lower than its 1-year high, and the market cap has also seen a decrease, raising questions about the stock's current valuation.

Social Dominance: 0.00547%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00547%
Daily Average: 0.00248%
[--] Week: 0.00542% +0.00502%
[--] Month: 0.01% +0.0093%
[--] Months: 0.01% +0.0096%
[--] Year: 0.01% +0.006%
1-Year High: 0.031% on 2025-06-29
1-Year Low: 0.0001% on 2025-08-09

Market Dominance: 0.00013217853443729305%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00013217853443729305%
Daily Average: 0%
1-Year High: 0.00513% on 2026-02-13
1-Year Low: 0.00013% on 2026-02-15

Market Cap: $116,715,123

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $116,715,123
Daily Average: $118,872,130
[--] Week: $116,267,939 +11%
[--] Month: $116,715,123 -4.70%
1-Year High: $132,366,576 on 2026-01-27
1-Year Low: $105,088,329 on 2026-02-05

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Genelux Corporation (GNLX)
/topic/$gnlx